TrialJournal of extracellular vesicles2025

Safety and Anti-Inflammatory Effects of Engineered Extracellular Vesicles (ILB-202) for NF-κB Inhibition: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial.

Seoyeon Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.